These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 9516081)

  • 1. The mannose 6-phosphate/insulin-like growth factor 2 receptor (M6P/IGF2R), a putative breast tumor suppressor gene.
    Oates AJ; Schumaker LM; Jenkins SB; Pearce AA; DaCosta SA; Arun B; Ellis MJ
    Breast Cancer Res Treat; 1998 Feb; 47(3):269-81. PubMed ID: 9516081
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mannose 6-phosphate/insulin-like growth factor 2 receptor, a bona fide tumor suppressor gene or just a promising candidate?
    DaCosta SA; Schumaker LM; Ellis MJ
    J Mammary Gland Biol Neoplasia; 2000 Jan; 5(1):85-94. PubMed ID: 10791771
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Altered ligand binding by insulin-like growth factor II/mannose 6-phosphate receptors bearing missense mutations in human cancers.
    Devi GR; De Souza AT; Byrd JC; Jirtle RL; MacDonald RG
    Cancer Res; 1999 Sep; 59(17):4314-9. PubMed ID: 10485478
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radiation-induced posttranscriptional control of M6P/IGF2r expression in breast cancer cell lines.
    Iwamoto KS; Barber CL
    Mol Carcinog; 2007 Jul; 46(7):497-502. PubMed ID: 17295243
    [TBL] [Abstract][Full Text] [Related]  

  • 5. M6P/IGF2 receptor: a candidate breast tumor suppressor gene.
    Hankins GR; De Souza AT; Bentley RC; Patel MR; Marks JR; Iglehart JD; Jirtle RL
    Oncogene; 1996 May; 12(9):2003-9. PubMed ID: 8649861
    [TBL] [Abstract][Full Text] [Related]  

  • 6. M6P/IGF2R is mutated in squamous cell carcinoma of the lung.
    Kong FM; Anscher MS; Washington MK; Killian JK; Jirtle RL
    Oncogene; 2000 Mar; 19(12):1572-8. PubMed ID: 10734317
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Loss of heterozygosity at the mannose 6-phosphate insulin-like growth factor 2 receptor (M6P/IGF2R) locus predisposes patients to radiation-induced lung injury.
    Kong FM; Anscher MS; Sporn TA; Washington MK; Clough R; Barcellos-Hoff MH; Jirtle RL
    Int J Radiat Oncol Biol Phys; 2001 Jan; 49(1):35-41. PubMed ID: 11163495
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decreased expression of the mannose 6-phosphate/insulin-like growth factor-II receptor promotes growth of human breast cancer cells.
    Chen Z; Ge Y; Landman N; Kang JX
    BMC Cancer; 2002 Jul; 2():18. PubMed ID: 12149131
    [TBL] [Abstract][Full Text] [Related]  

  • 9. M6P/IGF2R tumor suppressor gene mutated in hepatocellular carcinomas in Japan.
    Oka Y; Waterland RA; Killian JK; Nolan CM; Jang HS; Tohara K; Sakaguchi S; Yao T; Iwashita A; Yata Y; Takahara T; Sato S; Suzuki K; Masuda T; Jirtle RL
    Hepatology; 2002 May; 35(5):1153-63. PubMed ID: 11981765
    [TBL] [Abstract][Full Text] [Related]  

  • 10. M6P/IGF2R gene is mutated in human hepatocellular carcinomas with loss of heterozygosity.
    De Souza AT; Hankins GR; Washington MK; Orton TC; Jirtle RL
    Nat Genet; 1995 Dec; 11(4):447-9. PubMed ID: 7493029
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Loss of heterozygosity at the mannose 6-phosphate/insulin-like growth factor 2 receptor locus: a frequent but late event in adrenocortical tumorigenesis.
    Leboulleux S; Gaston V; Boulle N; Le Bouc Y; Gicquel C
    Eur J Endocrinol; 2001 Feb; 144(2):163-8. PubMed ID: 11182753
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is the mannose-6-phosphate/insulin-like growth factor 2 receptor coded by a breast cancer suppressor gene?
    Lemamy GJ; Sahla ME; Berthe ML; Roger P
    Adv Exp Med Biol; 2008; 617():305-10. PubMed ID: 18497053
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Imprinted genes in liver carcinogenesis.
    De Souza AT; Yamada T; Mills JJ; Jirtle RL
    FASEB J; 1997 Jan; 11(1):60-7. PubMed ID: 9034167
    [TBL] [Abstract][Full Text] [Related]  

  • 14. M6P/IGF2R modulates the invasiveness of liver cells via its capacity to bind mannose 6-phosphate residues.
    Puxbaum V; Nimmerfall E; Bäuerl C; Taub N; Blaas PM; Wieser J; Mikula M; Mikulits W; Ng KM; Yeoh GC; Mach L
    J Hepatol; 2012 Aug; 57(2):337-43. PubMed ID: 22521359
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutation analysis of the gene encoding the human mannose 6-phosphate/insulin-like growth factor 2 receptor (M6P/IGF2R) in human cell lines resistant to growth inhibition by transforming growth factor beta(1) (TGF-beta(1)).
    Gemma A; Hosoya Y; Uematsu K; Seike M; Kurimoto F; Yoshimura A; Shibuya M; Kudoh S
    Lung Cancer; 2000 Nov; 30(2):91-8. PubMed ID: 11086202
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dominant-negative effect of truncated mannose 6-phosphate/insulin-like growth factor II receptor species in cancer.
    Kreiling JL; Montgomery MA; Wheeler JR; Kopanic JL; Connelly CM; Zavorka ME; Allison JL; Macdonald RG
    FEBS J; 2012 Aug; 279(15):2695-713. PubMed ID: 22681933
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Loss of heterozygosity of M6P/IGF2R gene is an early event in the development of prostate cancer.
    Hu CK; McCall S; Madden J; Huang H; Clough R; Jirtle RL; Anscher MS
    Prostate Cancer Prostatic Dis; 2006; 9(1):62-7. PubMed ID: 16304558
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Imprinted M6p/Igf2 receptor is mutated in rat liver tumors.
    Mills JJ; Falls JG; De Souza AT; Jirtle RL
    Oncogene; 1998 May; 16(21):2797-802. PubMed ID: 9652747
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mannose 6-phosphate/insulin-like growth factor 2 receptor (M6P/IGF2R) variants in American and Japanese populations.
    Killian JK; Oka Y; Jang HS; Fu X; Waterland RA; Sohda T; Sakaguchi S; Jirtle RL
    Hum Mutat; 2001; 18(1):25-31. PubMed ID: 11438990
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of insulin-like growth factor II (IGF-II)-dependent cell growth by multidentate pentamannosyl 6-phosphate-based ligands targeting the mannose 6-phosphate/IGF-II receptor.
    Zavorka ME; Connelly CM; Grosely R; MacDonald RG
    Oncotarget; 2016 Sep; 7(38):62386-62410. PubMed ID: 27694692
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.